ENDOCYTE INC·4

Feb 11, 5:05 PM ET

APLIN JOHN C 4

4 · ENDOCYTE INC · Filed Feb 11, 2011

Insider Transaction Report

Form 4
Period: 2011-02-09
APLIN JOHN C
Director
Transactions
  • Conversion

    Common Stock

    2011-02-09+143,895143,895 total(indirect: By CID Seed Fund, L.P.)
  • Conversion

    Series C-1 Convertible Preferred Stock

    2011-02-09246,3800 total(indirect: By CID Equity Capital VIII, L.P.)
    Common Stock (246,380 underlying)
  • Conversion

    Series C-3 Convertible Preferred Stock

    2011-02-0941,8550 total(indirect: By CID Equity Capital VIII, L.P.)
    Common Stock (41,855 underlying)
  • Conversion

    Series C-1 Convertible Preferred Stock

    2011-02-09123,1900 total(indirect: By CID Seed Fund, L.P.)
    Common Stock (123,190 underlying)
  • Conversion

    Series C-3 Convertible Preferred Stock

    2011-02-0920,7050 total(indirect: By CID Seed Fund, L.P.)
    Common Stock (20,705 underlying)
  • Award

    Stock Option (right to buy)

    2011-02-09+15,70615,706 total
    Exercise: $7.23Exp: 2021-02-09Common Stock (15,706 underlying)
  • Conversion

    Common Stock

    2011-02-09+288,235288,235 total(indirect: By CID Equity Capital VIII, L.P.)
Footnotes (4)
  • [F1]Each share of the Issuer's Series A-1, Series A-2, Series B, Series C-1, Series C-2 and Series C-3 Preferred Stock automatically converted into shares of Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.
  • [F2]John Aplin is a Class A member of CID Equity Partners VIII, LLC, which has the ultimate voting and investment power over shares held of record by CID Equity Capital VIII, L.P., and he may be deemed to have voting and investment power over shares held of record by CID Equity Capital VIII, L.P. Mr. Aplin disclaims beneficial ownership of the shares directly held by the entities affiliated with CID except to the extent of his individual pecuniary interest therein.
  • [F3]John Aplin is a general partner of CID Seed Fund Partners I which has the ultimate voting and investment power over shares held of record by CID Seed Fund, L.P., and he may be deemed to have voting and investment power over shares held of record by CID Seed Fund, L.P. Mr. Aplin disclaims beneficial ownership of the shares directly held by the entities affiliated with CID except to the extent of his individual pecuniary interest therein.
  • [F4]Shares subject to the option vest 1/3 of the shares upon the business day before each of the Issuer's first three annual stockholder meetings following February 9, 2011.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION